Royal Bank of Canada Raises Korro Bio (NASDAQ:KRRO) Price Target to $90.00

Korro Bio (NASDAQ:KRROFree Report) had its target price upped by Royal Bank of Canada from $70.00 to $90.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other research analysts also recently issued research reports about the company. HC Wainwright reiterated a buy rating and issued a $100.00 price objective on shares of Korro Bio in a report on Friday, January 19th. BMO Capital Markets reiterated an outperform rating and issued a $120.00 price objective on shares of Korro Bio in a report on Tuesday.

Get Our Latest Stock Analysis on KRRO

Korro Bio Trading Up 1.7 %

Shares of NASDAQ KRRO opened at $90.00 on Wednesday. The business’s 50-day moving average is $56.31. Korro Bio has a 1-year low of $9.15 and a 1-year high of $97.91. The stock has a market cap of $66.60 million, a P/E ratio of -0.95 and a beta of 2.09.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Atlas Venture Life Science Advisors LLC purchased a new position in Korro Bio during the 4th quarter worth approximately $53,648,000. Eventide Asset Management LLC purchased a new position in Korro Bio during the 4th quarter worth approximately $26,185,000. 72 Investment Holdings LLC purchased a new position in Korro Bio during the 4th quarter worth approximately $13,269,000. Vanguard Group Inc. purchased a new position in Korro Bio during the 4th quarter worth approximately $12,988,000. Finally, Point72 Asset Management L.P. purchased a new position in Korro Bio during the 4th quarter worth approximately $12,741,000. Hedge funds and other institutional investors own 13.18% of the company’s stock.

Korro Bio Company Profile

(Get Free Report)

Korro Bio, Inc, a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc is based in Cambridge, Massachusetts.

Featured Stories

Receive News & Ratings for Korro Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Korro Bio and related companies with MarketBeat.com's FREE daily email newsletter.